{
  "table_name": "KIDNEY_NEPHRECTOMY",
  "description": "Stores data for College of American Pathologists (CAP) form 76027-KIDNEY: Nephrectomy, Partial or Radical.",
  "primary_key": {
    "column_name": "RESULT_ID",
    "ordinal_position": "1"
  },
  "columns": [
    {
      "index": 2,
      "name": "RESULT_ID",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "The unique identifier for the result record."
    },
    {
      "index": 7,
      "name": "TUMOR_SITE_SPECIFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify tumor site."
    },
    {
      "index": 12,
      "name": "CAP_COMMENTS",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: General comments."
    },
    {
      "index": 17,
      "name": "SPEC_PROC_SPECIFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify the Specimen Procedure."
    },
    {
      "index": 22,
      "name": "TUMOR_SIZE_GREAT",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Tumor Greatest Size."
    },
    {
      "index": 27,
      "name": "TUMOR_SIZE_ADDL",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Tumor Size (length)."
    },
    {
      "index": 32,
      "name": "TUMOR_SIZE_ADDL2",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Tumor Size (width)."
    },
    {
      "index": 37,
      "name": "TUMOR_SIZE_SPECIFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Tumor Size."
    },
    {
      "index": 42,
      "name": "HISTO_TYPE_SPECIFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify histologic type."
    },
    {
      "index": 47,
      "name": "SPECIFIC_MARGINS",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specific Margins."
    },
    {
      "index": 52,
      "name": "MACRO_EXTENT_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Macroscopic Extent."
    },
    {
      "index": 57,
      "name": "SARCOMATOID_FEAT_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Sarcomatoid Features.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nCannot be assessed\n\n\nNot identified\n\n\nAbsent\n\n\nPresent\n\n\nIndeterminate\n\n\nPortal vein invasion present\n\n\nHepatic vein invasion present\n\n\nPresent within tumor nodules\n\n\nPresent in vessels of parenchyma outside of tumor nodules\n\n\nCannot be determined"
    },
    {
      "index": 74,
      "name": "PERCN_SARCOMAT_ELEM",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Percentage Sarcomatoid Element."
    },
    {
      "index": 79,
      "name": "FUHRMAN_NUCLR_GRD_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Histologic Grade (Fuhrman Nuclear Grade).\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nNot applicable\n\n\nGX: Cannot be assessed\n\n\nG1: Nuclei round, uniform, approximately 10 �m; nucleoli inconspicuous or absent\n\n\nG2: Nuclei slightly irregular, approximately 15 �m; nucleoli evident\n\n\nG3: Nuclei very irregular, approximately 20 �m; nucleoli large and prominent\n\n\nG4: Nuclei bizarre and multilobated, 20 �m or greater, nucleoli prominent, chromatin \n\n\nOther"
    },
    {
      "index": 93,
      "name": "FUHR_NUCLR_GRD_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Histologic Grade (Fuhrman Nuclear Grade) Specify."
    },
    {
      "index": 98,
      "name": "DIRECTLY_INVADS_ADJ",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Tumor directly invades other adjacent organs."
    },
    {
      "index": 103,
      "name": "NECROSIS_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Necrosis.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nNot identified\n\n\nPresent\n\n\nPresent, focal (small foci or single cell necrosis)\n\n\nPresent, central (expansive \"comedo\" necrosis)\n\n\nNot applicable\n\n\nCannot be determined"
    },
    {
      "index": 116,
      "name": "OTHER_TUMOR_SPECIFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Other Tumors."
    },
    {
      "index": 121,
      "name": "CYSTS_TYPE_SPECIFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Cyst Type."
    },
    {
      "index": 126,
      "name": "PRIMARY_TUMOR_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Primary Tumor (pT).\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\npTX: Cannot be determined\n\n\npTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or\n\n\npTX: Cannot be assessed\n\n\npT0: No evidence of primary tumor\n\n\npTis: Carcinoma in situ\n\n\npTis (DCIS): Ductal carcinoma in situ\n\n\npTis (LCIS): Lobular carcinoma in situ\n\n\npTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and\n\n\npTis: Carcinoma in situ, intraepithelial (no invasion)\n\n\npTis: Carcinoma in situ, invasion of lamina propria\n\n\npTis: High-grade dysplasia / carcinoma in situ\n\n\npTis: Tubal intraepithelial carcinoma (limited to tubal mucosa)\n\n\npTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I)\n\n\nEncapsulated\n\n\nExtracapsular extension without adjacent organ involvement\n\n\nExtension into adjacent organs\n\n\nExtension into spinal canal\n\n\npTa: Papillary noninvasive carcinoma\n\n\npTa: Noninvasive papillary carcinoma\n\n\npTis: Intratubular germ cell neoplasia only (carcinoma in situ)\n\n\npTis: Flat carcinoma in situ\n\n\npTis: Carcinoma in situ: flat tumor\n\n\nIris\n\n\nCiliary Body and Choroid\n\n\npT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion\n\n\npT1: Tumor limited to ampulla of Vater or sphincter of Oddi\n\n\npT1: Tumor 2 cm or less in greatest dimension\n\n\npT1: Tumor invades submucosa\n\n\npT1: Tumor confined to the bile duct histologically\n\n\npT1: Solitary tumor without vascular invasion\n\n\npT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue\n\n\npT1: Tumor 8 cm or less in greatest dimension\n\n\npT1mi: Tumor <= 1 mm in greatest dimension (microinvasion)\n\n\npT1a: Tumor > 1 mm but <= 5 mm in greatest dimension\n\n\npT1b: Tumor > 5 mm but <= 10 mm in greatest dimension\n\n\npT1c: Tumor > 10 mm but <= 20 mm in greatest dimension\n\n\npT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium\n\n\npT1b (IB): Tumor invades greater than or equal to one-half of the myometrium\n\n\npT1: Tumor invades lamina propria, muscularis mucosae, or submucosa\n\n\npT1a: Tumor invades lamina propria or muscularis mucosae\n\n\npT1a: Tumor invades lamina propria\n\n\npT1 (I): Tumor limited to fallopian tube(s)\n\n\npT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites\n\n\npT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites\n\n\npT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa\n\n\npT1b: Tumor invades submucosa\n\n\npT1b: Tumor invades muscle layer\n\n\npT1: Tumor 7 cm or less in greatest dimension, limited to the kidney\n\n\npT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney\n\n\npT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to  kidney\n\n\npT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura\n\n\npT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by \n\n\npT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I)\n\n\npT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or\n\n\npT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or\n\n\npT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm\n\n\npT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm\n\n\npT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N\n\n\npT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface\n\n\npT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule \n\n\npT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension\n\n\npN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen\n\n\npT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal\n\n\npT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen\n\n\npT1: Tumor invades subepithelial connective tissue (lamina propria)\n\n\npT1: Tumor confined to the eye with no optic nerve or choroidal invasion\n\n\npT1a: Tumor 5 cm or less in greatest dimension, superficial tumor\n\n\npT1b: Tumor 5 cm or less in greatest dimension, deep tumor\n\n\npT1: Tumor 2 cm or less in greatest dimension with less than two high risk features\n\n\npT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion\n\n\npT1: Tumor size 2 cm or less, limited to thyroid\n\n\npT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid\n\n\npT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid\n\n\npT1 (I): Tumor confined to uterus\n\n\npT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically\n\n\npT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less\n\n\npT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth\n\n\npT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2\n\n\npT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension\n\n\npT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension\n\n\npT1 (I): Tumor confined to vaginal wall\n\n\npT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum\n\n\npT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more\n\n\npT2: Tumor greater than 5 cm, no extra-adrenal invasion\n\n\npT2: Tumor invades duodenal wall\n\n\npT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension\n\n\npT2: Tumor invades muscularis propria\n\n\npT2: Tumor invades beyond the wall of the bile duct\n\n\npT2a: Solitary tumor with vascular invasion\n\n\npT2b: Multiple tumors, with or without vascular invasion\n\n\npT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue\n\n\npT2b: Tumor invades adjacent hepatic parenchyma\n\n\npT2: Tumor more than 8 cm in greatest dimension\n\n\npT2: Tumor > 20 mm but <= 50 mm in greatest dimension\n\n\npT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend \n\n\npT2 (II): Tumor involves 1 or both tube(s) with pelvic extension\n\n\npT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries\n\n\npT2b (IIB): Extension to other pelvic structures\n\n\npT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites\n\n\npT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver\n\n\npT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm\n\n\npT2: Tumor more than 7 cm in greatest dimension, limited to the kidney\n\n\npT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney\n\n\npT2b: Tumor more than 10 cm, limited to the kidney\n\n\npT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension\n\n\npT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l\n\n\npT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension\n\n\npT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension)\n\n\npT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, \n\n\npT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration\n\n\npT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration\n\n\npT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell\n\n\npT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or\n\n\npT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant\n\n\npT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension\n\n\npN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than \n\n\npT2: Tumor with parapharyngeal extension\n\n\npT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or\n\n\npT2: Organ confined\n\n\npT2a: Unilateral, involving one-half of 1 side or less\n\n\npT2b: Unilateral, involving more than one-half of 1 side but not both sides\n\n\npT2c: Bilateral disease\n\n\npT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion\n\n\npT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion\n\n\npT2a: Tumor more than 5 cm in greatest dimension, superficial tumor\n\n\npT2b: Tumor more than 5 cm in greatest dimension, deep tumor\n\n\npT2: Tumor greater than 2 cm in greatest dimension with or without one additional\n\n\npT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion\n\n\npT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid \n\n\npT2 (II): Tumor extends outside of the uterus but is limited to genital structures\n\n\npT2a: Tumor invades superficial muscularis propria (inner half)\n\n\npT2b: Tumor invades deep muscularis propria (outer half)\n\n\npT2a (IIA): Tumor without parametrial invasion\n\n\npT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen\n\n\npT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension\n\n\npT2b (IIB): Tumor with parametrial invasion\n\n\npT2 (II): Tumor invades paravaginal tissues but not the pelvic wall\n\n\npT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures \n\n\npT3: Tumor of any size with local invasion, but not invading adjacent organs\n\n\npT3: Tumor invades pancreas\n\n\npT3: Tumor more than 5 cm in greatest dimension\n\n\npT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix\n\n\npT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of\n\n\npT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas\n\n\npT3: Tumor invades unilateral branches of the portal vein or hepatic artery\n\n\npT3: Discontinuous tumors in primary bone site (not including skip metastases)\n\n\npT3: Tumor > 50 mm in greatest dimension\n\n\npT3: Tumor invades through the muscularis propria into pericolorectal tissues\n\n\npT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis)\n\n\npT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve\n\n\npT3: Tumor invades adventitia\n\n\npT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis\n\n\npT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis\n\n\npT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen\n\n\npT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen\n\n\npT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver\n\n\npT3a: Multiple tumors more than 5 cm\n\n\npT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins\n\n\npT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal\n\n\npT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) \n\n\npT3b: Tumor grossly extends into the vena cava below the diaphragm\n\n\npT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava\n\n\npT3: Mucosal disease\n\n\npT3: Tumor more than 4 cm in greatest dimension\n\n\npT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that\n\n\npT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I)\n\n\npT3: Locally advanced but potentially resectable tumor that involves all of the\n\n\npT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration\n\n\npT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration\n\n\npT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor)\n\n\npT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen\n\n\npT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen\n\n\npT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or \n\n\npT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis\n\n\npT3: Tumor invades bony structures of skull base and / or paranasal sinuses\n\n\npT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary\n\n\npT3a: Extraprostatic extension or microscopic invasion of bladder neck\n\n\npT3b: Seminal vesicle invasion\n\n\npT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma\n\n\npT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion\n\n\npT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion\n\n\npT3: Tumor invades through the muscularis propria into the subserosa or into the\n\n\npT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone\n\n\npT3: Tumor invades subserosal connective tissue, without involvement of\n\n\npT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion\n\n\npT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension\n\n\npT3: Tumor invades beyond muscularis propria into periureteric fat\n\n\npT3a: Microscopically\n\n\npT3b: Macroscopically (extravesicular mass)\n\n\npT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall\n\n\npT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney\n\n\npT3 (III): Tumor extends to pelvic wall\n\n\npT3 (FIGO IVA): Tumor of any size with extension to any of the following\n\n\npT4: Tumor of any size with invasion of adjacent organs\n\n\npT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures\n\n\npT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder\n\n\npT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within\n\n\npT4: Tumor involves the celiac axis or the superior mesenteric artery\n\n\npT4: Tumor with periductal invasion\n\n\npT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati\n\n\npT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa \n\n\npT4: Tumor invades adjacent structures \n\n\npT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic\n\n\npT4: Tmr w/ direct invasion of adj. organs other than gallbladder \n\n\npT4: Tmr invades beyond Gerota�s fascia\n\n\npT4: Tumor of any size that invades any of the following: mediastinum, heart, great\n\n\npT4: Locally advanced technically unresectable tumor involving all of the ipsilateral\n\n\npT4: Tumor with intracranial extension and / or involvement of cranial nerves,\n\n\npT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J)\n\n\npT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat\n\n\npT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified\n\n\npT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified\n\n\npT4: Tumor with direct or perineural invasion of skull base or axial skeleton\n\n\npT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure\n\n\npT4: Tumor invades scrotum with or without vascular / lymphatic invasion\n\n\npT4: Tumor invades adjacent organs\n\n\npT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis\n\n\npT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis\n\n\npT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi\n\n\npT4a: Tumor penetrates the visceral peritoneum\n\n\npT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas\n\n\npT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria\n\n\npT4c: Both T4a and T4b\n\n\npT4d: Inflammatory carcinoma\n\n\npT4b: Tumor directly invades other organs or structures\n\n\npT4b: Tumor directly invades or is adherent to other organs or structures\n\n\npT4a: Resectable tumor invading pleura, pericardium, or diaphragm\n\n\npT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body\n\n\nAny T / Any N and M1 (IV): Distant metastasis including presence of malignant cells\n\n\nPrimary Tumor (pT): Supraglottis\n\n\nPrimary Tumor (pT): Glottis\n\n\nPrimary Tumor (pT): Subglottis\n\n\npT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone,\n\n\npT4b: Very advanced disease. Tumor involving brain, dura, skull base,\n\n\npT4a: Moderately advanced local disease.\n\n\npT4b: Very advanced local disease. \n\n\npT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal,\n\n\npT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates\n\n\npT4a: Melanoma greater than 4.0 mm in thickness, no ulceration\n\n\npT4b: Melanoma greater than 4.0 mm in thickness, with ulceration\n\n\nPrimary Tumor (pT): Maxillary Sinus\n\n\nPrimary Tumor (pT): Nasal Cavity and Ethmoid Sinus\n\n\npT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic\n\n\npT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid \n\n\npT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage,\n\n\npT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases\n\n\npT4a: Tumor involves visceral peritoneum (serosal surface)\n\n\npT4b: Tumor directly invades adjacent structures\n\n\npT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid\n\n\npT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid\n\n\npT4a: Intrathyroidal anaplastic carcinoma-surgically resectable\n\n\npT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable\n\n\npT4a: Tumor invades prostatic stroma or uterus or vagina\n\n\npT4b: Tumor invades pelvic wall or abdominal wall\n\n\nNot identified"
    },
    {
      "index": 388,
      "name": "REGIONL_LYMPH_ND_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Regional Lymph Nodes (pN).\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\npNX: Cannot be assessed\n\n\npN0: No regional lymph node metastasis\n\n\npN1: Regional lymph node metastasis\n\n\npN1: Metastasis in perirectal lymph nodes\n\n\npN1: Metastasis in 1 to 3 regional lymph nodes\n\n\npN1a: Metastasis in 1 regional lymph node\n\n\npN1b: Metastasis in 2 to 3 regional lymph nodes\n\n\npN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta\n\n\npN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes\n\n\npN1: Regional lymph node metastasis involving 1 to 2 nodes\n\n\npN1 (IIIC): Regional lymph node metastasis\n\n\npN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery\n\n\npN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension\n\n\npN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes, \n\n\npN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes\n\n\npN1a: Clinically occult (microscopic) metastasis\n\n\npN1b: Clinically apparent (macroscopic) metastasis\n\n\npN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension\n\n\npN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension\n\n\npN1: Metastasis in 1 to 2 perigastric lymph nodes\n\n\npN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension,\n\n\npN1a: Nodal metastases to Level VI lymph nodes\n\n\npN1b: Metastases to unilateral, bilateral or contralateral cervical \n\n\npN1: Single regional lymph node metastasis in the true pelvis \n\n\npN1 (IVB): Pelvic or inguinal lymph node metastasis\n\n\npN1: Metastasis in regional lymph node or nodes\n\n\npN1: Regional lymph node involvement (preauricular, cervical, submandibular)\n\n\npN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s)\n\n\npN2: Metastasis in 4 or more regional lymph nodes\n\n\npN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd\n\n\npN2a: Metastasis in 4 to 6 regional lymph nodes\n\n\npN2b: Metastasis in 7 or more regional lymph nodes\n\n\npN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho\n\n\npN2: 3 to 6 nodes involved\n\n\npN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n\n\n\npN2: Metastasis in a single ipsilateral lymph node, more than 3 cm\n\n\npN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than\n\n\npN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension\n\n\npN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension\n\n\npN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen.\n\n\npN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s)\n\n\npN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes \n\n\npN2a: Clinically occult (microscopic) metastasis\n\n\npN2b: Clinically apparent (macroscopic) metastasis\n\n\npN2c: Satellite or in-transit metastasis without nodal metastasis\n\n\npN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension\n\n\npN2: Metastasis in a single regional lymph node, more than 2 cm but not more than\n\n\npN2: Metastasis in 3 to 6 perigastric lymph nodes\n\n\npN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm \n\n\npN2: Multiple regional lymph node metastasis in the true pelvis \n\n\npN2: Distant lymph node involvement\n\n\npN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il\n\n\npN3: 7 or more nodes involved\n\n\npN3: Metastasis in a lymph node more than 6 cm in greatest dimension\n\n\npN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or\n\n\npN3: Metastases in the contralateral mediastinal, contralateral internal mammary,\n\n\npN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or\n\n\npN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa\n\n\npN3a: Greater than 6 cm in dimension\n\n\npN3b: Extension to the supraclavicular fossa\n\n\npN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension\n\n\npN3: Metastasis in 7 or more perigastric lymph nodes\n\n\npN3a: Metastasis in 7 to 15 perigastric lymph nodes\n\n\npN3b: Metastasis in 16 or more perigastric lymph nodes\n\n\npN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension\n\n\npN3: Lymph node metastasis to the common iliac lymph nodes\n\n\npN1: One or two regional lymph nodes with the following features\n\n\npN2 (FIGO IIIB): Regional lymph node metastasis with the following features\n\n\npN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis"
    },
    {
      "index": 464,
      "name": "REG_LN_NUM_EXM",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Regional Lymph Nodes Number Examined."
    },
    {
      "index": 469,
      "name": "REG_LN_NUM_INV",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Regional Lymph Nodes Number Involved."
    },
    {
      "index": 474,
      "name": "DISTNT_METASTASIS_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Distant Metastasis.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nNot applicable\n\n\ncM0 (i+): No clinical or radiographic evidence of distant metastasis\n\n\npM0: No distant metastasis\n\n\npM1: Distant metastasis\n\n\npM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx\n\n\npM1b: Nonperitoneal metastasis\n\n\npM1: Distant detectable metastasis as determined by classic clinical\n\n\npM1 (IVB): Distant metastasis\n\n\npM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or\n\n\npM1b: Distant metastases outside the lung / pleura\n\n\npM1: Distant metastasis (documented in this specimen)\n\n\npM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes\n\n\npM1b: Metastasis to lung\n\n\npM1c: Metastasis to all other visceral sites or distant metastasis at any site\n\n\npM1a: Nonregional lymph node(s)\n\n\npM1b: Bone(s)\n\n\npM1c: Other site(s) with or without bone disease\n\n\npM1: Metastasis to sites other than CNS\n\n\npM1a: Single lesion\n\n\npM1b: Multiple lesions\n\n\npM1c: CNS metastasis\n\n\npM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement\n\n\npM1e: Leptomeningeal and / or CSF involvement\n\n\npM1a: Non-regional lymph nodes or pulmonary metastasis\n\n\npM1b: Distant metastasis other than to nonregional lymph nodes and lungs\n\n\npM1a (III): Tumor extends to the lungs with or without genital tract involvement\n\n\npM1b (IV): Tumor involves other metastatic sites\n\n\npM1a: Largest diameter of the largest metastasis 3 cm or less\n\n\npM1b: Largest diameter of the largest metastasis 3.1-8.0 cm\n\n\npM1c: Largest diameter of the largest metastasis 8 cm or more\n\n\npM1a: Lung\n\n\npM1b: Metastasis involving distant sites other than lung (including skip metastases)\n\n\nDistant Metastasis present (includes metastasis to lymph nodes)"
    },
    {
      "index": 514,
      "name": "GLOMERULAR_DIS_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Glomerular disease."
    },
    {
      "index": 519,
      "name": "TUBULNTST_DIS_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Tubulointerstitial disease."
    },
    {
      "index": 524,
      "name": "VASCULAR_DIS_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Vascular disease."
    },
    {
      "index": 529,
      "name": "PATH_NON_KIDNY_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Pathologic Findings in Nonneoplastic Kidney."
    }
  ]
}
